Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Transplantation, Homologous × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma 4 Leukemia, Myeloid, Acute 4 Leukemia 3 Waldenstrom Macroglobulinemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Spondylolisthesis 1 Spinal Stenosis 1 Spinal Cord Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Intervertebral Disc Displacement 1 Intervertebral Disc Degeneration 1 Hodgkin Disease 1 Failed Back Surgery Syndrome 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Radiation 4 Irinotecan 4 Cyclophosphamide 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Observation 2 Methotrexate 2 Methods 2 Ipilimumab 2 Interviews as Topic 2 Injections 2 Indocyanine Green 2 Ifosfamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00841152 2021-03-16

BAGvsTCP

Turku University Hospital

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡